We envision the Centre as an umbrella for the scientific community within this research area, providing a common hub where new research collaborations and ideas can evolve and take the field to the next level. We organize events for the community regularly.
The Centre is a strategic initiative from Haukeland University Hospital at Helse Bergen Health Trust and the Faculty of Medicine at the University of Bergen, financed by Trond Mohn Foundation for five years. MRCRM builds on an active research environment and the newly established Ex vivo facility at the Laboratory building at Haukeland. This laboratory is a high-grade cleanroom facility operating under Good Manufacturing Practice (GMP) and will manufacture the cells for clinical trials affiliated with the Centre.
The initial research projects affiliated to the Centre, and recruited through a generous grant by the Trond Mohn Foundation are presented below.
The objectives of the MRCRM are to coordinate groundbreaking fundamental research, and give patients access to state-of-the-art therapies, initially in clinical trials but later as established advanced, personalized treatment, see below. We will achieve this by:
Being the hub for the scientific community
Supporting and promoting fundamental and translational stem cell research
Enabling clinical trials with advanced therapy medicinal products (ATMPs) based on tissues and cells, employing the new GMP laboratory at Haukeland
Assisting in steering through the approval process by the Norwegian Medicinal Agency
Implementing novel therapies using ATMPs
Read more about our events and the MRCRM seminar series here
Read more about the new clean-room cell production laboratory called the Ex vivo facility.
In August 2021, the Helse Bergen Health Trust and the University of Bergen established the Mohn Research Centre for Regenerative Medicine. Four research projects, recruited through grants from the Trond Mohn Foundation, comprise the initial scientific foundation of the Centre.
The Trond Mohn Foundation has generously supported the initiative with 30 MNOK, and the host institutions have contributed with in total 60 MNOK. The Helse Bergen Health Trust has also invested a considerable amount in the new “Ex Vivo” cell production facility, which will be operable at Haukeland University Hospital by the end of 2022.
The administrative unit of the Centre is located at the Department of Immunology and Transfusion Medicine in the Laboratory Building at Haukeland University Hospital. Still, our research is spread to dedicated laboratories and buildings around Bergen. Thus, so far this is a centre “without walls”.
The MRCRM Team
The appointed centre leader is Professor and MD Einar K. Kristoffersen, Head of the Department of Immunology and Transfusion Medicine at Haukeland University Hospital. He chairs the MRCRM Management group
, which meets monthly to discuss strategic and practical issues.
The MRCRM Steering Group
is chaired by the Helse Bergen deputy CEO Clara Gjesdal, and consists of representatives from the Helse Bergen Health Trust, the University of Bergen and the Trond Mohn Foundation.
An international Scientific Advisory Board
(SAB) has been established and consists of representatives with high compentency on cell therapy and research centre development. The role of the SAB is to support and evaluate the Centre.
Are you working with regenerative medicine? Join the Centre!
Mohn Research Centre for Regenerative Medicine is an umbrella for the entire research community in Bergen and Western Norway, and we are planning seminar series
and educational events.
The Mohn Research Centre for Regenerative Medicine is supported by the Trond Mohn Foundation, University of Bergen, and Haukeland University Hospital.